Watch SMTI. Know when insiders buy.
One email the day a filing lands. Free.
SMTI
Sanara MedTech Inc.
35.12
+0.06 +0.17%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $322.7MP/E —DIV YIELD —FCF YIELD 1.40%REV TTM $109.8M +13.0%NET INCOME −$32MNET DEBT $31.1M52W 16.34 – 35.28SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $28.1M | +9.0% | 93.0% | $1.8M | −$453K | — | -0.05 | $2M | $5K | $2M | Aug 11 |
| Q1 2026 · Mar 31 | $27.8M | +18.6% | 93.1% | $2.6M | $459K | — | 0.05 | −$2.5M | $44K | −$2.5M | May 12 |
| Q4 2025 · Dec 31derived | $27.5M | +4.7% | 93.2% | $1.1M | −$1.6M | — | -0.32 | $3.9M | $82K | $3.9M | Mar 24 |
| Q3 2025 · Sep 30 | $26.3M | +21.5% | 92.9% | $2.9M | −$30.4M | — | -3.40 | $2.2M | $1.1M | $1.1M | Nov 12 |
| Q2 2025 · Jun 30 | $25.8M | +28.0% | 92.5% | $2.5M | −$2M | — | -0.23 | $2.7M | $1.8M | $903K | Aug 11 |
| Q1 2025 · Mar 31 | $23.4M | +26.4% | 92.2% | $826K | −$3.5M | — | -0.41 | −$2M | $1.7M | −$3.7M | May 12 |
| Q4 2024 · Dec 31derived | $26.3M | +48.7% | 91.4% | $2.3M | −$1.5M | — | -0.18 | $932K | $72K | $860K | Mar 24 |
| Q3 2024 · Sep 30 | $21.7M | +35.2% | 90.8% | $779K | −$2.9M | — | -0.34 | $2.1M | $9K | $2M | Nov 12 |
| Q2 2024 · Jun 30 | $20.2M | — | 90.0% | −$2.9M | −$3.5M | — | -0.41 | −$1.4M | $59K | −$1.5M | Aug 13 |
| Q1 2024 · Mar 31 | $18.5M | — | 89.8% | −$1.5M | −$1.8M | — | -0.21 | −$1.6M | $66K | −$1.7M | May 14 |
| Q4 2023 · Dec 31derived | $17.7M | — | 89.9% | −$226K | −$237K | — | -0.03 | −$849K | $54K | −$903K | Mar 25 |
| Q3 2023 · Sep 30 | $16M | — | 89.1% | −$907K | −$1.1M | — | -0.13 | $1.1M | $170K | $894K | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $103.1M | 92.7% | $7.3M | −$37.6M | -36.4% | -4.36 | $6.8M | $4.6M | $2.2M | — | — |
| FY2024 · to Dec 31 | $86.7M | 90.6% | $1.3M | −$9.7M | -11.2% | -1.14 | −$24K | $206K | −$230K | — | — |
| FY2023 · to Dec 31 | $65M | 87.9% | −$4.2M | −$4.3M | -6.6% | -0.52 | −$3.2M | $265K | −$3.5M | — | — |
| FY2022 · to Dec 31 | $45.8M | 86.1% | −$12.5M | −$7.9M | -17.3% | -1.00 | −$5.6M | $147K | −$5.7M | — | — |
| FY2021 · to Dec 31 | $24.1M | 90.4% | −$7.4M | −$7.9M | -32.8% | -1.08 | −$4.8M | $172K | −$5M | — | — |
| FY2020 · to Dec 31 | $15.6M | 89.6% | −$5M | −$4.4M | -28.5% | -0.76 | −$4M | $544K | −$4.6M | — | — |
Every number comes from Sanara MedTech Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.